1. Home
  2. RANI vs GIFT Comparison

RANI vs GIFT Comparison

Compare RANI & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • GIFT
  • Stock Information
  • Founded
  • RANI 2012
  • GIFT 1999
  • Country
  • RANI United States
  • GIFT United States
  • Employees
  • RANI N/A
  • GIFT N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • GIFT Catalog/Specialty Distribution
  • Sector
  • RANI Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • RANI Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • RANI 41.6M
  • GIFT 37.1M
  • IPO Year
  • RANI 2021
  • GIFT N/A
  • Fundamental
  • Price
  • RANI $1.31
  • GIFT $1.03
  • Analyst Decision
  • RANI Strong Buy
  • GIFT
  • Analyst Count
  • RANI 5
  • GIFT 0
  • Target Price
  • RANI $11.80
  • GIFT N/A
  • AVG Volume (30 Days)
  • RANI 420.9K
  • GIFT 87.0K
  • Earning Date
  • RANI 11-14-2024
  • GIFT 02-15-2025
  • Dividend Yield
  • RANI N/A
  • GIFT N/A
  • EPS Growth
  • RANI N/A
  • GIFT N/A
  • EPS
  • RANI N/A
  • GIFT N/A
  • Revenue
  • RANI N/A
  • GIFT $86,439,146.00
  • Revenue This Year
  • RANI N/A
  • GIFT N/A
  • Revenue Next Year
  • RANI N/A
  • GIFT N/A
  • P/E Ratio
  • RANI N/A
  • GIFT N/A
  • Revenue Growth
  • RANI N/A
  • GIFT N/A
  • 52 Week Low
  • RANI $1.24
  • GIFT $0.50
  • 52 Week High
  • RANI $8.75
  • GIFT $4.55
  • Technical
  • Relative Strength Index (RSI)
  • RANI 35.89
  • GIFT N/A
  • Support Level
  • RANI $1.24
  • GIFT N/A
  • Resistance Level
  • RANI $1.61
  • GIFT N/A
  • Average True Range (ATR)
  • RANI 0.11
  • GIFT 0.00
  • MACD
  • RANI 0.02
  • GIFT 0.00
  • Stochastic Oscillator
  • RANI 18.92
  • GIFT 0.00

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: